EuroSCORE II Explained: What This European Cardiac Surgery Risk Score Means for Your Heart Surgery Decision

What Is the EuroSCORE II Calculator and Why Should You Care?

If you or someone you love is facing heart surgery, you have probably heard your surgeon or cardiologist mention a "risk score." One of the most commonly referenced tools worldwide is the EuroSCORE II calculator — a European cardiac surgery risk score that estimates your chance of dying during or shortly after heart surgery.

That sounds blunt, and it is. But understanding what this number means, how it was built, and where it falls short can help you make a more informed decision about your care. As a board-certified cardiovascular surgeon, I use risk scores like EuroSCORE II and the STS score regularly. Neither one tells the whole story, but both are important pieces of the puzzle.

This article will walk you through EuroSCORE II in plain language — what it calculates, how it differs from the American STS risk model, and what you should actually do with the number you are given.

How the European Cardiac Surgery Risk Score Works

EuroSCORE stands for the European System for Cardiac Operative Risk Evaluation. The original version (EuroSCORE I) was introduced in 1999 and was based on data from nearly 20,000 patients across 128 hospitals in eight European countries. It was a major step forward — the first widely validated tool that let surgeons estimate operative mortality before a patient went to the operating room.

However, cardiac surgery evolved. Techniques improved. Patient populations changed. By the late 2000s, EuroSCORE I was consistently overestimating risk — telling patients their surgery was more dangerous than it actually was. This mattered because inflated risk scores were being used to justify less-proven interventions (like early transcatheter valve procedures) in patients who might have done better with conventional surgery.

In 2012, EuroSCORE II was released, built on data from over 22,000 patients across 43 countries. It uses 18 variables grouped into three categories:

• Patient-related factors: Age, sex, kidney function (creatinine clearance), presence of chronic lung disease, poor mobility, history of prior cardiac surgery, active endocarditis, diabetes on insulin, and overall functional status (NYHA class).
• Cardiac-related factors: Severity of angina (CCS class), left ventricular function, recent heart attack, pulmonary artery pressure.
• Surgery-related factors: Urgency of the operation (elective vs. emergency vs. salvage), type of procedure, whether the thoracic aorta is involved, and the number of procedures being performed simultaneously.

These variables are entered into a logistic regression model that produces a predicted mortality percentage. For example, a EuroSCORE II of 1.5% means the model estimates a 1.5% chance of dying during the hospital stay or within 30 days of surgery.

You can try a risk calculator that incorporates these types of variables using our free cardiac surgery risk calculator.

EuroSCORE vs STS: Understanding the Two Major Risk Models

In the United States, the dominant risk prediction tool is the STS (Society of Thoracic Surgeons) risk score. In Europe and much of the rest of the world, EuroSCORE II is the standard. If you are seeking opinions from both American and international physicians, you may encounter both scores — and they will not always agree.

Here are the key differences between the two:

Data Sources

The STS score is built on data from over 6 million cardiac surgery cases in the STS Adult Cardiac Surgery Database — the largest and most continuously updated registry in the world. It is predominantly North American. EuroSCORE II is based on a smaller but multinational dataset and has not been updated with the same frequency.

What They Predict

EuroSCORE II predicts in-hospital or 30-day mortality — a single number. The STS score predicts mortality and several other outcomes: stroke, renal failure, prolonged ventilation, deep sternal wound infection, reoperation, and a composite measure called "major morbidity or mortality." This makes the STS score more informative in practice, because surviving surgery is not the only thing that matters. A patient may survive but suffer a disabling stroke — and the STS model accounts for that risk separately.

Procedure-Specific Calibration

The STS has distinct, separately calibrated models for isolated CABG, isolated valve replacement, and combined procedures. EuroSCORE II uses a single model for all cardiac operations, adjusting for procedure type as one of its input variables. The STS approach tends to be more precise for specific operations.

Calibration and Accuracy

Multiple validation studies have shown that EuroSCORE II can overestimate risk in low-risk patients and underestimate risk in very high-risk patients. A 2014 study in the European Journal of Cardio-Thoracic Surgery found that EuroSCORE II had reasonable discrimination (it ranked patients well from low to high risk) but imperfect calibration (the actual percentages were sometimes off). The STS models, recalibrated regularly against current data, tend to have better calibration in North American populations — but may be less applicable in healthcare systems with different patient demographics and practice patterns.

The bottom line: neither model is perfect. Both are useful tools, but a number on a screen should never replace clinical judgment from an experienced surgeon who knows your specific anatomy, comorbidities, and goals.

What Your EuroSCORE II Result Actually Means — And What It Does Not

Let me be direct about something I see regularly in my practice. Patients come to me with a printed risk score and ask, "Is this number good or bad?" The answer is more nuanced than a simple threshold.

Here are some general ranges to help you contextualize a EuroSCORE II result:

• Less than 2%: Low risk. Most straightforward cardiac operations in otherwise healthy patients fall here. Expected outcomes are excellent.
• 2% to 5%: Moderate risk. This is common for patients with multiple medical issues or more complex operations. Surgery is still generally favorable but warrants careful planning.
• Greater than 5%: Elevated risk. This does not mean surgery should not happen — it means the risks and benefits need particularly thoughtful analysis. Many patients in this range still benefit enormously from surgery.
• Greater than 10%: High risk. At this level, the conversation often shifts to whether less invasive approaches (like TAVR for aortic stenosis) or medical management might offer a better risk-benefit balance.

But here is what these numbers cannot tell you:

• They do not account for your specific surgeon's skill or experience. A complex operation done by a high-volume surgeon at a specialized center may carry substantially less real-world risk than the model predicts.
• They do not weigh quality of life. A predicted 4% mortality may be entirely acceptable to a 72-year-old who wants to return to playing tennis. It may not be acceptable to someone who is frail and would likely face a long, uncertain recovery regardless of survival.
• They do not factor in anatomical details. A heavily calcified aorta, prior chest radiation, or a porcelain ascending aorta can dramatically change operative risk in ways that no calculator captures.

Risk scores are the beginning of a conversation, not the end of one. If you have been told your risk is "too high" for surgery — or, conversely, that your risk is "so low" that you do not need to think twice — it is worth having an independent surgeon evaluate your case. Our cardiac second opinion service exists precisely for this purpose.

When EuroSCORE II Gets Used to Make Decisions About Your Care

One of the most consequential uses of the EuroSCORE II calculator is in the decision between conventional surgery and transcatheter interventions — particularly TAVR vs. surgical aortic valve replacement (SAVR) for aortic stenosis.

According to current European Society of Cardiology (ESC) and ACC/AHA guidelines, patients are typically classified into risk categories using EuroSCORE II or the STS score. These categories help determine whether a patient should be offered TAVR, SAVR, or a discussion with a multidisciplinary Heart Team:

• Low-risk patients (EuroSCORE II less than 4%, STS less than 4%): Guidelines generally favor SAVR for younger patients, though recent trial data has expanded the role of TAVR here as well.
• Intermediate-risk patients: Either approach may be appropriate, and the decision should involve shared decision-making.
• High-risk or prohibitive-risk patients: TAVR is often preferred when anatomy is suitable.

The problem arises when risk scores are applied rigidly. I have reviewed cases where a patient was directed toward TAVR based on an elevated EuroSCORE II, when the score was inflated by factors that would not actually increase their surgical risk in the hands of an experienced team. A EuroSCORE II of 6% in a vigorous 68-year-old with well-controlled diabetes tells a very different story than the same score in an 85-year-old with severe frailty.

This is precisely why a second set of eyes matters. If your treatment recommendation is being driven primarily by a risk score rather than a comprehensive clinical assessment, you owe it to yourself to get another opinion.

Practical Advice: How to Use Risk Scores as a Patient

Here is what I tell my patients about cardiac surgery risk assessment:

• Ask for your score. Whether it is a EuroSCORE II, an STS score, or both — you have every right to know the numbers being used to guide your treatment plan. Ask your surgeon what model they are using and what your predicted risk is.
• Ask what the score does not capture. Request a conversation about factors specific to you — your anatomy, your activity level, your recovery potential — that may not be reflected in any calculator.
• Compare when possible. If you have access to both a EuroSCORE II and an STS score, compare them. Significant discrepancies are not unusual, and understanding why the numbers differ can be illuminating.
• Do not let a number make your decision for you. A risk score is a statistical estimate based on populations. You are not a population. You are a person with a unique combination of factors that requires individualized analysis.
• Consider a second opinion from a surgeon. Not a cardiologist. Not a database. A surgeon who operates on cases like yours, who can look at your imaging and tell you what they would actually expect in the operating room.

If you want to get a quick sense of where you stand, start with our free cardiac surgery risk calculator. It takes just a few minutes and gives you a baseline to discuss with your medical team.

The Bottom Line on EuroSCORE II

The EuroSCORE II calculator is a valuable and widely used tool for predicting surgical mortality. It has helped standardize risk assessment across countries and institutions, and it provides a useful common language between patients and their care teams. But like any statistical model, it has limitations — it can overestimate or underestimate your actual risk, it does not account for surgeon or hospital quality, and it cannot weigh the deeply personal factors that should influence your decision.

Understanding the difference between EuroSCORE vs STS scoring is especially important if you are comparing recommendations from physicians in different countries or healthcare systems. Neither score is inherently superior — they are complementary tools that work best when interpreted by an experienced surgeon who treats your case as more than a collection of data points.

If you are facing a cardiac surgery decision and want to understand what your risk score truly means for your specific situation, a WhiteGloveMD second opinion can help. Our reviews are conducted by a board-certified cardiovascular surgeon who will evaluate your imaging, medical records, and risk profile — then provide you with a clear, honest, and actionable assessment. Because when it comes to your heart, you deserve more than a number.